Combination of IVIG and Corticosteroids Superior to Respective Monotherapies for Treatment of Relapsed ITP in Adults
The combination of intravenous immune globulin (IVIG) and corticosteroids is a more efficient and rapid treatment for relapsed immune thrombocytopenic purpura (ITP) in adults compared with the use of either therapy alone.
Early Albumin Administration May Reduce Mortality in Septic Shock and ARDS: Retrospective MIMIC III Database Study
A study has found that early albumin administration in septic shock patients with ARDS was independently associated with a reduction in 28-day mortality.
FDA Approves Antibody to Protect Infants Against RSV
The U.S. Food and Drug Administration (FDA) has approved nirsevimab to protect newborns from respiratory syncytial virus (RSV).
Immunotherapy May Treat ALS, Says Study
A study led by scientists at Oregon Health & Science University has found that a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis (ALS).
Myths & Facts: Obsessive-Compulsive Disorder
OCD is no joke, and the rash of hurtful memes about the condition minimize the amount of suffering that people with OCD live through on a daily basis. But perhaps by understanding OCD, how it affects those who suffer from it and how it is treated, the ignorant, albeit mostly innocent, statements such as “I’m so OCD!” will cease.
$147 Million Awarded to Help End the HIV Epidemic in the U.S.
The U.S. Department of Health and Human services has awarded more than $147 million to 49 recipients to advance the Ending the HIV Epidemic in the U.S. initiative, which is part of the ongoing efforts to reduce the number of new infections in the United States by at least 90 percent by 2030.
Update on Child Hepatitis
An unusual uptick in pediatric hepatitis recently put the medical community on edge. Here’s what we know, why it matters and what to do to mitigate the condition going forward.
The 2022 Childhood Hepatitis Outbreak: What We Know Now
The mystery behind the sudden outbreak of acute severe hepatitis in 2022 is revealed.
Merck’s Ebola Vaccine Approved for the Pediatric Population
An expanded indication for ERVECO for the prevention of disease caused by Zaire ebolavirus in individuals 12 months of age and older has been approved by the U.S. Food and Drug Administration.
Study Finds Immunotherapy Causes Chronic Side Effects
A recent study has found chronic immune-related side effects are common in patients with skin cancer who are treated with postsurgical Opdivo (nivolumab) or Keytruda (pembrolizumab), although for some individuals, these toxicities resolve by the 18-month mark.